HLS Therapeutics Inc. — Form D
HLS Therapeutics Inc. of CALEDON, A6, a company, filed a Form D exempt-offering notice with the SEC on 2015-07-17. The offering totals $112.8M, of which $112.8M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2015-07-17
- Form: D
- Accession: 0001648315-15-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $112.8M
- Amount sold: $112.8M
- Minimum investment: $25K
- Investors: 22
- Date of first sale: 2015-07-02
- Revenue range: Decline to Disclose
- SEC file number: 021-243945
Issuer
- Name: HLS Therapeutics Inc.
- CIK: 0001648315
- Entity type: Corporation
- Jurisdiction: BRITISH COLUMBIA, CANADA
- Incorporated: 2014
- Address: 17474 HUMBER STATION ROAD, CALEDON, A6, L7E 0Z2
- Phone: 416-624-6568
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Bill D Wells | Director | Caledon, A6 |
| Gilbert D Godin | Director | Caledon, A6 |
| Gilbert D Godin | Executive Officer | Caledon, A6 |
| Chris D Fibiger | Executive Officer | Caledon, A6 |
| Joseph D MacLean | Director | Caledon, A6 |
| Joseph D MacLean | Executive Officer | Caledon, A6 |
| Gregory D Gubitz | Director | Caledon, A6 |
| Gregory D Gubitz | Executive Officer | Caledon, A6 |
| Gregory D Gubitz | Promoter | Caledon, A6 |
Other filings by this issuer (1)
More